Thought Leadership | AGC Biologics

1 min read

Webinar: What can plug-and-play offer large-scale AAV manufacturing?

March 16, 2022 at 7:34 AM

Thought Leadership Cell & Gene Therapy

Read article

Patricia Massera quote: Both immuno-oncology and cell and gene therapies have the potential to collide and produce fantastic results.

2 min read

Cancer and Rare Disease: What Progress Can Be Expected in these Fields in 2022 and beyond?

January 14, 2022 at 9:00 AM

Thought Leadership Other Media

Read article

Patricio Massera quote: Research shows that a similar type cell therapy-based personalized medicine, allogenic treatments, holds the potential for quicker, more efficacious, and more accessible therapies

1 min read

Personalized Medicine in 2022: Allogeneic Treatments Can be the Effective “Brick in the Wall” for Cell and Gene Therapy Treatments

January 13, 2022 at 9:00 AM

Thought Leadership Other Media

Read article

Cell and Gene therapy Downstream Process Development

2 min read

AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space

October 20, 2021 at 4:15 PM

Events Thought Leadership Cell & Gene Therapy AAV vector manufacturing

Read article

1 min read

AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021

September 17, 2021 at 1:34 AM

Events Cell & Gene Therapy Virtual Site Tour

Read article

Our Company

Locations

Policies

Offerings

Services

AGC’s DNA-to-IND Program

News

Resources

Fact Sheets

Join Us

What Drives Us

Meet Our Teams

AGC Biologics

Webinar: What can plug-and-play offer large-scale AAV manufacturing?

Cancer and Rare Disease: What Progress Can Be Expected in these Fields in 2022 and beyond?

Personalized Medicine in 2022: Allogeneic Treatments Can be the Effective “Brick in the Wall” for Cell and Gene Therapy Treatments

AGC Biologics Solves Capacity Shortages in Cell and Gene Therapy Space

AGC Biologics Offers Virtual Tour of Expanded Milan Cell & Gene Therapy Center During European Biotech Week 2021

Our Mission

Links

News

AGC Biologics to Prepare Late-Phase and Commercial Runs for Immunocore

Events

Advanced Therapies Week, January 16-19